145 related articles for article (PubMed ID: 15699627)
21. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells.
Krug A; Rothenfusser S; Hornung V; Jahrsdörfer B; Blackwell S; Ballas ZK; Endres S; Krieg AM; Hartmann G
Eur J Immunol; 2001 Jul; 31(7):2154-63. PubMed ID: 11449369
[TBL] [Abstract][Full Text] [Related]
22. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
23. The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets.
Hemmi H; Kaisho T; Takeda K; Akira S
J Immunol; 2003 Mar; 170(6):3059-64. PubMed ID: 12626561
[TBL] [Abstract][Full Text] [Related]
24. CpG-B ODNs potently induce low levels of IFN-alphabeta and induce IFN-alphabeta-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs.
Gray RC; Kuchtey J; Harding CV
J Leukoc Biol; 2007 Apr; 81(4):1075-85. PubMed ID: 17227820
[TBL] [Abstract][Full Text] [Related]
25. The immunostimulatory effect of CpG oligodeoxynucleotides on peripheral blood mononuclear cells of healthy dogs and dogs with atopic dermatitis.
Jassies-van der Lee A; Rutten V; Spiering R; van Kooten P; Willemse T; Broere F
Vet J; 2014 Apr; 200(1):103-8. PubMed ID: 24461202
[TBL] [Abstract][Full Text] [Related]
26. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
Iho S; Yamamoto T; Takahashi T; Yamamoto S
J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958
[TBL] [Abstract][Full Text] [Related]
27. Species-Specific Minimal Sequence Motif for Oligodeoxyribonucleotides Activating Mouse TLR9.
Pohar J; Lainšček D; Fukui R; Yamamoto C; Miyake K; Jerala R; Benčina M
J Immunol; 2015 Nov; 195(9):4396-405. PubMed ID: 26416273
[TBL] [Abstract][Full Text] [Related]
28. CpG-C ISS-ODN activation of blood-derived B cells from healthy and chronic immunodeficiency virus-infected macaques.
Teleshova N; Kenney J; Williams V; Van Nest G; Marshall J; Lifson JD; Sivin I; Dufour J; Bohm R; Gettie A; Pope M
J Leukoc Biol; 2006 Feb; 79(2):257-67. PubMed ID: 16443827
[TBL] [Abstract][Full Text] [Related]
29. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
Yu C; An M; Li M; Liu H
Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
[TBL] [Abstract][Full Text] [Related]
30. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung.
Ashino S; Wakita D; Zhang Y; Chamoto K; Kitamura H; Nishimura T
Int Immunol; 2008 Feb; 20(2):259-66. PubMed ID: 18156622
[TBL] [Abstract][Full Text] [Related]
31. Type I interferon is required to mount an adaptive response to immunostimulatory DNA.
Van Uden JH; Tran CH; Carson DA; Raz E
Eur J Immunol; 2001 Nov; 31(11):3281-90. PubMed ID: 11745345
[TBL] [Abstract][Full Text] [Related]
32. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
Front Immunol; 2018; 9():783. PubMed ID: 29720976
[TBL] [Abstract][Full Text] [Related]
33. Requirements for effective inhibition of immunostimulatory CpG motifs by neutralizing motifs.
Zhao H; Cheng SH; Yew NS
Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):381-9. PubMed ID: 11079577
[TBL] [Abstract][Full Text] [Related]
34. CpG oligonucleotides as immune adjuvants.
Krieg AM
Ernst Schering Res Found Workshop; 2000; (30):105-18. PubMed ID: 10943319
[No Abstract] [Full Text] [Related]
35. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of human immunodeficiency virus gp120 and Tat on CpG-A-induced inflammatory cytokines in plasmacytoid dendritic cells.
Fang M; Xu N; Shao X; Yang J; Wu N; Yao H
Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):797-804. PubMed ID: 22814248
[TBL] [Abstract][Full Text] [Related]
37. Anti-proliferative effects of phosphodiester oligodeoxynucleotides.
Bjersing JL; Tarkowski A; Collins LV
Immunobiology; 2004; 209(8):637-45. PubMed ID: 15638132
[TBL] [Abstract][Full Text] [Related]
38. CpG-containing oligodeoxynucleotides induce TNF-alpha and IL-6 production but not degranulation from murine bone marrow-derived mast cells.
Zhu FG; Marshall JS
J Leukoc Biol; 2001 Feb; 69(2):253-62. PubMed ID: 11272276
[TBL] [Abstract][Full Text] [Related]
39. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides.
Zelenay S; Elías F; Fló J
Eur J Immunol; 2003 May; 33(5):1382-92. PubMed ID: 12731065
[TBL] [Abstract][Full Text] [Related]
40. C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level.
Jurk M; Schulte B; Kritzler A; Noll B; Uhlmann E; Wader T; Schetter C; Krieg AM; Vollmer J
Immunobiology; 2004; 209(1-2):141-54. PubMed ID: 15481148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
